Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
126 Cards in this Set
- Front
- Back
What are the ways hemostasis is controlled?
|
1. Vascular contraction
2. Platelet adhesion, activation, aggregation 3. Fibrin formation/reinforcement of the platelet plug |
|
What prompts smooth m. contraction in vessels?
|
Exposure to plasma
|
|
What is thromboxane A2 released by?
|
Platelets
|
|
What is the role of serotonin in hemostasis?
|
It mediates vasospasm
|
|
What does the loss of NO do?
|
Causes vasospasm
|
|
What normally inhibits clotting?
|
Prostacyclin
|
|
What endogenous chemicals inhibit the clotting cascade?
|
-Heparin sulfate
-Antithrombin -Protein C&S -Tissue factor pathway inhibitor |
|
Prostacyclin (PGI2)
|
-Metabolite of arachidonic acid
-Synthesized by endothelial cells -Inhibits platelet aggregation and secretion |
|
What is the role of nitric oxide?
|
-It is a vasodilator
-It also inhibits platelet activity |
|
What makes NO?
|
Nitric oxide synthase
|
|
What component of blood is antithrombin?
|
Plasma protein
|
|
What is antithrombin job?
|
Inhibits activated clotting factors
|
|
What synthesizes endogenous heparin?
|
Endothelial cells
|
|
What is heparin's job?
|
Accelerates the activity of antithrombin
|
|
What do Protein C&S do when they form activated protein C?
|
It inhibits clotting by degrading factors 5a and 8a
|
|
What activates Protein C&S?
|
Thrombin in the presence of thrombomodulin on endothelial cells
|
|
Where in the plasma is TFPI found?
|
In the lipoprotein fraction
|
|
What is the job of TFPI?
|
Binds and inhibits factor 10a
|
|
What are the steps to platelet adhesion and plug formation?
|
1. Platelets bind to exposed collagen
2. Plates are activated, releasing thromboxane A2 and ADP 3. Platelets bind via fibrinogen and GPIIb/IIIa |
|
What are the steps to forming thrombin?
|
VII→VIIa→X→Xa→Prothrombin→
Thrombin |
|
What is the aPTT used for?
|
To monitor HEPARIN levels via the intrinsic pathway
|
|
What is the PT used for?
|
It is a measure of the extrinsic pathway and it used to monitor WARFARIN
|
|
What are the steps to fibrinolysis?
|
Plasminogen→Plasmin→Fibrin→
Degradation of fibrin clot |
|
What turns off tPA?
|
Plasminogen activator inhibitor
|
|
Warfarin (Coumadin)
|
-Indications: prevents emboli, DVT, thromboembolism
-MOA: Vit K inhibitor; decreases synthesis of 2, 7, 9, 10 -Adverse rxns: bleeding, hyperthyroidism, teratogenic, |
|
ASA
|
-Indications: emboli, MI protection
-MOA: inhibits platelet aggregation by inhibits thromboxane A2 -Adverse effects: bleeding, CI a surgery, allergy |
|
Clopidogrel (Plavix)
|
-Indications: MI, ASA allergy
-MOA: inhibits platelet aggregation via antagonising ADP receptor; no effect on prostaglandins-less GI effect -Adverse effects: bleeding |
|
Abciximab (ReoPro)
|
-Indications: AMI, unstable angina, angioplasty, atherectomy, stent placement, PCI
-MOA: inhibits platelet aggregation by binding to fibrinogen and vWF -Adverse effects: bleeding, thrombocytopenia, cost |
|
Heparin
|
-Indications: venous thromboemboli, adjunct in STEMI/NSTEMI
-MOA: enhances action of antithrombin III -Adverse effects: osteoporosis, allergic rxns, decrease in platelets, bleeding; CI in: hemophilia, thrombocytopenia, purpura, HTN, ICH, infective endocarditis, active TB, ulcers, threatened abortion, visceral carcinoma, hepatic/renal dz (advanced), sx, LP |
|
Protamine Sulfate
|
-Indications: heparin antagonist
-MOA: binds to heparin -Adverse effects: w/o heparin, can act as an anticoagulant; hypotension (histamine release), pulmonary HTN, allergic rxns |
|
When is Lovenox indicated?
|
In pregnancy as a safe alternative. It is lmw heparin.
|
|
Lepirudin (Refludan)
|
-Indications: heparin-induced thrombocytopenia
-MOA: specific, direct inhibitor of thrombin -Adverse effects: |
|
tPA
|
-Indications: thrombolytic
-MOA: converts plasminogen to plasmin; active against fibrin-bound plasminogen, making clot-selective at high doses -Adverse effects: cost |
|
Streptokinase (Streptase)
|
-Indications: thrombolytic
-MOA: forms complex with proactivator-activates plasminogen -Adverse effects: allergic rxns, not fibrin specific (systemic fibrinolysis); most effective at first dose |
|
Aminocaproic acid (Amicar)
|
-Indications: bleeding, hyperfibrinolysis, porphylaxis against re-bleeding in ICH; hemophilia adjunct
-MOA: completely inhibits plasminogen formation; inhibits fibrinolytic activity and reverses action of fibrinolytic drugs -Adverse effects: toxic w/tranexamic acid (causes intravascular thrombosis); hypotension, myopathy, GI discomfort, nasal stuffiness |
|
How and when is histamine released?
|
It is released by mast cells in response to stimulation by allergens.
|
|
What receptors does histamine act upon?
|
H1, H2, H3, H4
|
|
Where are H1 receptors found?
|
-Smooth muscle
-Brain -Endothelium |
|
What signaling mechanism does H1 use?
|
IP3-DAG (Gq)
|
|
Where are H2 receptors found?
|
-GI
-Cardiac muscle -Mast cells -Brain |
|
How do H2 receptors signal?
|
cAMP (Gs)
|
|
Where are H3 receptors found?
|
Presynaptic
|
|
Where are H4 receptors found?
|
Immune cells
|
|
How do H3/H4 receptors signal?
|
Gi
|
|
What is histamine's effect on the nervous system?
|
-Uticaria
-Via H1 |
|
What is the triple response?
|
-Stimulation of these cell types that cause flare/wheal
1. Sense nerve endings (H1): px/uticaria 2. Microvascular SM (H1/H2): redness (flushing) 3. Capillary endothelium (H1): edema |
|
What are histamines effects on the CV system?
|
-Arteriodilatory (H1/H2): direct (H2); indirect (H1) via NO; causes hypotension, flush, HA, warmth
-Increased HR (H2): direct and indirect (reflex tachycardia), direct increase in contractility -Edema (H1): separation of post-capillary endothelial cells; uticaria/hives |
|
What are histamine's effects upon bronchiolar smooth muscle?
|
-Bronchoconstriction (H1)
-Diagnostic use for asthma is only pharmacological use of exogenous histamine |
|
What are histamine's effects upon the GI tract?
|
-Contraction of smooth muscle (H1)
-Increased acid secretion (H2) -Decreased acid secretion (H3) |
|
Diphenhydramine (Benadryl)
|
-Indications: allergic rxns, motion sickness, sleep aid, local anesthetic
-MOA: non-selective H1 antagonist; sig anticholinergic activity -Adverse effects: sedation, anti-muscarinic effects, excitation/convulsions in peds, postural hypotension (a1 inhibition) |
|
Fexofenadine (Allegra)
|
-Indications: allergic rxns
-MOA: metabolite of Seldane; antagonizes peripheral H1 receptors -Adverse effects: HA, dyspepsia, cough |
|
Loratadine (Claritin)
|
-Indications: allergic rxns
-MOA: selective peripheral H1 antagonist -Adverse effects: |
|
Bradykinin
|
-Vasodilatory peptide
-Dilates aa in kidney, heart, intestine, skeletal muscle, liver -Receptors: B1/B2; B2 responsible for most effects -Metabolized by ACE |
|
Are B2 receptors inducible?
|
Yes
|
|
What does serotonin do?
|
In the vasculature, it contricts vessels
-Metabolized by MAO -Mainly found in enterocromaffin cells in GI tracts; also found in platelets and CNS -All serotonin receptors are GPCR except for 5HT3 which is Na/K |
|
What happens in the two phases of migrane HA?
|
Phase 1: vasoconstriction of intracranial aa leading to ischemia (aura)
Phase 2: vasodilation and pulsation of dural and extracranial vessels |
|
Where does the px associated with migraine come from?
|
It is caused by vasodilation/inflammation due to the release of vasoactive peptides like Substance P and Calcitonin gene-related peptide
|
|
What are the s/sx associated with cluster HA?
|
-Severe unilateral, retro-orbital, burning px
-Sensitivity to movement, light, noise |
|
What are the s/sx associated with tension HA?
|
-Mild to moderate B, band-like, non-pulsating px
|
|
Dihydroergotamine (DHE/Migranal)
|
-Indications: migrane HA
-MOA: constrict dilated aa by stimulating 5HT1 receptors; most effective/specific for acute attacks early on -Adverse effects: powerful vasoconstrictor; not for use in preggos |
|
Sumatriptan (Imitrex)
|
-Indications: migrane HA
-MOA: vasoconstriction via selective stimulation of 5HT1D receptors -Adverse effects: CI: vascular/heart dz, diabetes, preggos |
|
Methysergide (Sansert)
|
-Indications: migraine HA porphylaxis
-MOA: weak vasoconstriction via blockage of 5HT2 receptors |
|
What are the effects of NSAIDs?
|
-Fever reduction
-Reduce chronic px -Platelet inhibition -Reduce inflammation |
|
What is ASA's MOA?
|
Irreversible inhibitor of COX1 & 2
|
|
What are the adverse effects of ASA?
|
-Increased bleeding, ulcers, GI upset
-Asthma, hypersensitivity, hepatotoxicity, nephrotoxicity -Urate excretion -Reye's syndrome |
|
What are the s/sx associated with salicylism?
|
-Vomiting, tinnitus, hearing loss, vertigo
|
|
Levothyroxine
|
-Indications: hypothyroidism
-MOA: synthetic T4 -Adverse effects: hyperthyroidism |
|
Methimazole
|
-Indications: hyperthyroidism; Grave's dz
-MOA: decrease synthesis/release of T4 -Adverse effects: goiter; cretinism/goiter in fetus during preg |
|
Potassium Iodide
|
-Indications: radiation exposure
-MOA: rapidly decreases synthesis/release of T4/T3 -Adverse effects: |
|
I131
|
-Indications: tx hyperthyroidism
-MOA: destroys gland through radiation exposure -Adverse effects:thyroid storm, hypothyroidism, |
|
Propranolol
|
-Indications: symptomatic tx of hyperthyroidism
-MOA: non-selective B-blocker; blocks sympathetic activation of tissues; can also reduce peripheral conversion of T4 to T3 -Adverse effects: fatigue, dizziness, hypotension |
|
What do the glucocorticoids do?
|
Indications: adrenal insuff, immunosuppresion, RA, asthma, dermatologic conditions, CA
|
|
What are the adverse effects of corticoid use?
|
-Increased risk of infections; can mask s/sx
-Hyperglycemia: can unmask diabetes -Osteoporosis: this is the most limiting side effect; 30-50% -CNS: restlessness, insomnia, psychotic rxns, euphoria, increased appetite -Iatrogenic adrenal insufficiency: depression of the HPA due to abrupt cessation |
|
What are the clinical guidelines to corticosteriod tx?
|
-Give sufficient amt to control problem
-Use smallest effective dose for shortest time -Locally is better -Alternate days -Slowly taper withdrawal |
|
What are the sex steroids MOA?
|
-They inhibit ovulation by stopping the LH surge
-Changes cervical mucosa to block sperm -Changes endometrium to decrease implantation |
|
What are the side effects of sex steroids?
|
-Wt gain, nausea, edema
-Migraine, CV probs, depression |
|
Tamoxifen
|
-Indications: breast CA
-MOA: selective estrogen receptor modulator -Adverse effects: |
|
Anastrozole
|
-Indications: breast CA refractory to tamoxifen or in post-menopausal women
-MOA: aromatase inhibitor; inhibits synthesis of estrogen -Adverse effects: can have menopausal side effects |
|
Finasteride
|
-Indications: BPH; male pattern baldness
-MOA: converts testosterone into dihydrotestosterone; inhibts 5a-reductase -Adverse effects: |
|
Lispro
|
Rapid acting insulin
|
|
Regular insulin
|
Short acting insulin
|
|
NPH
|
Intermediate acting insulin
|
|
Lantus
|
Long acting insulin
|
|
What are the adverse effects associated with insulin use?
|
-Hypoglycemia
-Lipodystrophy -Hypersensitivity |
|
What is insulin's MOA?
|
-It promotes entry of glucose into skeletal muscle, heart muscle, and fat tissue.
-It inhibits catabolic processes such as the breakdown of glycogen, fat, and protein; promotes an anabolic state |
|
Glyburide
|
-Indications: NIDDM; hyperglycemia; sulfonylureas
-MOA: stimulates insulin release; reduces [glucagon], increases insulin's effects -Adverse effects: hypoglycemia |
|
Metformin
|
-Indications: hyperglycemia in NIDDM; biguanides
-MOA: decreases hepatic glucose output to decrease [glucose]; reduces LDL/VLDL -Adverse effects: diarrhea, nausea, lactic acidosis |
|
Acarbose
|
-Indications: hyperglycemia; a-glucosidase inhibitor
-MOA: decreases absorption of starch and disaccharides from intestine -Adverse effects: cramping, diarrhea, farts |
|
Pioglitazone
|
-Indications: hyperglycemia; thiazolidindiones
-MOA: lowers insulin resistance; decreases triglycerides over time; causes insulin effects post-receptor; increases glucose transporter synthesis in adipose -Adverse effects: edema, CV risk |
|
Exenatide (Byetta)
|
-Indications: hyperglycemia; NIDDM
-MOA: increases insulin; slows gastric empyting; inhibits glucagon -Adverse effects: |
|
Sitagliptin
|
-Indications: hyperglycemia; NIDDM
-MOA: DPP-IV inhibitor; increases the effects of endogenous incretin hormones -Adverse effects: |
|
Omeprazole (Prilosec)
|
-Indications: GERD
-MOA: proton pump inhibitor; binds irreversibly to pumps and inactivates it -Adverse effects: may increase risk of osteoporosis |
|
H2 receptors anatagonists (Famotidine, Cimetidine)
|
-Indications: GERD
-MOA: competes with histamine at H2 receptors on parietal gastric cells; inhibits basal and meal stimulated acid secretion -Adverse effects: Cimetidine inhibits CYP450s of other drugs; anti-androgenic |
|
Gastric antacids (Tums, MOM)
|
-Indications: symptomatic relief of upset stomach, heartburn
-MOA: neutralize acids to form salts and water; -Adverse effects: Mg salts increase motility and cause diarrhea; Al salts relax smooth muscle and cause constipation |
|
Misoprostol
|
-Indications: protects stomach from long term NSAID use
-MOA: inhibits acid secretion and stimulates bicarb/mucus release by stimulating prostaglandin receptors; prostaglandin E1 analog -Adverse effects: can stimulate uterine contractions; CI in preggos |
|
Glucocorticoids
|
-Indications: induces remission of IBD
-MOA: inhibits production of inflammatory cytokines and other proteins involved in inflammation -Adverse effects: PR admin |
|
Aminossalicytes (mesalamine, asacol)
|
-Indications: induces/maintains remission of IBD; not as effective w/Crohn's
-MOA: mech unk -Adverse effects: multiple, GI related |
|
Immunosuppresive agents (Infliximab, Remicade)
|
-Indications: maintain remission in IBD
-MOA: AB for TNFa -Adverse effects: |
|
Metoclopramide (Reglan)
|
-Indications: antiemetic; increases gastric motility;
-MOA: DA D2 receptor antagonist (prevents smooth muscle relaxation); increases ACh release (increases smooth muscle toneof upper GI); decreases reflux from stomach into esophagus -Adverse effects: |
|
Psyllium
|
-Indications: laxative
-MOA: bulk forming; stimulates peristalsis -Adverse effects: constipation |
|
Docusate
|
-Indications: constipation
-MOA: incorporates water into poop -Adverse effects: |
|
Magnesium hydroxide
|
-Indications: laxative
-MOA: attract/retain water; stimulates peristalsis -Adverse effects: not for constipation; CI: suspected blockage |
|
Biscodyl
|
-Indications: laxative
-MOA: act directly upon intestinal mucosa to enhance secretion and peristalsis -Adverse effects: cramps, loss of electrolytes |
|
Lubiprostone
|
-Indications: constipation, idiopathic
-MOA: prostaglandin E1 derivative; increases gastric motility; activates Cl C2 channels -Adverse effects: |
|
Bismuth subsalicylate
|
-Indications: diarrhea, infectious
-MOA: inhibits intestinal secretions -Adverse effects: |
|
Loperamide, Diphenoxylate plus atropine
|
-Indications: diarrhea
-MOA: stim constriction of circular and relaxation of longitudinal muscles -Adverse effects: CNS effects, resp depression |
|
How does cholera cause diarrhea?
|
Cholera toxin stimulates cAMP levels; this in turn results in increased secretion of water/electrolytes by intestinal mucosa
|
|
Ondasteron
|
-Indications: antiemetic
-MOA: blocks 5HT3 receptors in GI, solitary tract, and CTZ. Prevents stimulation of peripheral and central CTZ -Adverse effects: |
|
How does metoclopramide and phenothiazies work to prevent emesis?
|
By blocking D2 receptors in the solitary tract nucleus and CTZ.
|
|
Aprepitant
|
-Indications: antiemetic
-MOA: blocks neurokinin 1 receptors in the solitary tract -Adverse effects: |
|
Scopolamine
|
-Indications: antiemetic
-MOA: blocks M1 receptors in vestibular tracts, the solitary tract, and CTZ -Adverse effects: |
|
Meclizine, Antivert
|
-Indications: antiemetics
-MOA: blocks H1 receptors in the vestibular tract, the solitary nucleus, and CTZ -Adverse effects: |
|
Dronabinol
|
-Indications: antiemetic
-MOA: THC -Adverse effects: |
|
Prednisone
|
-Indications: severe asthma
-MOA: decrease airway inflammation; long term tx -Adverse effects: osteoporosis, immunosuppression, hyperglycemia |
|
Fluticasone
|
-Indications: mod to severe asthma; use w/ B2 agonists
-MOA: decrease airway inflammation; corticosteroid -Adverse effects: |
|
Cromolyn (Intal)
|
-Indications: asthma
-MOA: stabilizes plasma membrane (by inhibiting Ca2+ influx) of mast cells preventing degranulation; inhibits release of histamine, leukotrienes; does not affect bronchodilation or IgE binding -Adverse effects: bad taste |
|
Omalizumab
|
-Indications: chronic/severe asthma
-MOA: inhibits binding of IgE to mast cells; stabilizes mast cell membrane -Adverse effects: allergic rxn |
|
What are leukotrienes?
|
They are archidonic acid metabolites that are made by mast cells. They activate leukotriene type 1 receptors in smooth muscle, endothelial cells, and WBCs. Stim leads to inflammation and bronchoconstriction
|
|
Zileuton
|
-Indications: asthma
-MOA: inhibits 5' lipoxygenase; anti-leukotriene -Adverse effects: hepatotoxicity |
|
Monotelukast
|
-Indications: allergic asthma
-MOA: leukotriene antagonist -Adverse effects: few side effects; CI in severe asthma |
|
Salmeterol
|
-Indications: long-term tx of asthma
-MOA: B2 agonist; increase cAMP -Adverse effects: tachycardia |
|
Theophylline
|
-Indications: COPD, asthma
-MOA: inhibits breakdown of cAMP; antagonizes adenosine receptors in smooth muscles, causing relaxation, inhibits Ca2+; stim catecholamine release; CNS stimulant -Adverse effects: CNS effects, GI effects, cardiac effects; [plasma] relevant |
|
Tiotropium, Ipratropium
|
-Indications: COPD, asthma; viral/allergic rhinitis
-MOA: bronchodilation by blocking vagus stim; inhibits ACh -Adverse effects: |
|
Menthol
|
-Indications: antitussive
-MOA: anesthetizes afferent nerves in upper airway -Adverse effects: |
|
Dextromethorphan, et al
|
-Indications: antitussive
-MOA: inhibit cough center in the dorsal medulla w/o euphoria/analgesia -Adverse effects: |
|
Guaifenesin
|
-Indications: expectorant
-MOA: reduces surface tension and adhesiveness of lung secretion; facilitates expectoration -Adverse effects: |